TrialArthritis research & therapy2021

Ixekizumab, with or without concomitant methotrexate, improves signs and symptoms of PsA: week 52 results from Spirit-P1 and Spirit-P2 studies.

Bernard Combe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.